A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain

scientific article published on 01 May 2020

A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1126/SCIIMMUNOL.ABA6466
P698PubMed publication ID32358170

P50authorVincent PavotQ82514506
Darin K EdwardsQ89438716
Gary J NabelQ89723358
Kurt A SwansonQ94482478
Jennifer N Rainho-TomkoQ94482481
Zachary P WilliamsQ94482484
Michael KishkoQ94482488
Nicholas JacksonQ94482491
Heesik YoonQ94482494
Chih-Jen WeiQ94482498
P2093author name stringMichael Peredelchuk
Haritha Adhikarla
Linong Zhang
Sudha Chivukula
Scott Gallichan
Sankalp Gupta
Judith Alamares-Sapuay
Lilibeth Lanza
P2860cites workDoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopyQ37401395
P433issue47
P921main subjectnanoparticleQ61231
P577publication date2020-05-01
P1433published inScience ImmunologyQ27727580
P1476titleA respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain
P478volume5

Reverse relations

cites work (P2860)
Q100958685A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone
Q99637405A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice
Q100466517Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines

Search more.